676265-54-6Relevant articles and documents
CXCR3 RECEPTOR AGONISTS
-
, (2018/03/25)
Compounds are provided having the structure of the following Formula I: where R, R1, R2, R3a and R3b are as defined herein. Pharmaceutical compositions comprising such compounds, as well as methods related to their manufacture and use, are also provided.
IRAK INHIBITORS AND USES THEREOF
-
, (2015/11/16)
The present invention provides quinazoline and quinoline compounds, compositions thereof, and methods of using the same. Also disclosed is the activity of such compounds as inhibitors of IRAK enzymes.